Nick M. Clayton - Concepedia

Author

Nick M. Clayton

GlaxoSmithKline (United Kingdom)

Also Known As

N Clayton, N M Clayton, N. Clayton, N. M. CLAYTON, N. M. Clayton, N.M. Clayton, Nick Clayton, Nick M. Clayton

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)University of Sheffield University of Hertfordshire

About

Nick M. Clayton is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, pharmacology, and pain medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	665
2	Health Sciences	8	8	386
3	Natural Sciences	3	3	126
4	Education	1	1	42
5	Allergy	1	1	11

Nick M. Clayton

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain Nick M. Clayton, Fiona H. Marshall, C. Bountra, Pain	2002	238
GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain Jorge De Alba, Nick M. Clayton, S D Collins, Pain Acute PainPain MedicineNitric OxideNeuropathic PainRat Models	2005	130
Discovery of 2-[(2,4-Dichlorophenyl)amino]- <i>N</i> -[(tetrahydro- 2 <i>H</i> -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain Gerard M.P. Giblin, Celestine T. O’Shaughnessy, Alan Naylor, Journal of Medicinal Chemistry	2007	120
Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat Steven J. R. Elmes, Lisa Winyard, Stephen J. Medhurst, Pain Paw OedemaAcute PainPain MedicineImmunologyNeuropathic Pain	2005	96
Review article: the therapeutic potential of 5‐HT<sub>3</sub>receptor antagonists in the treatment of irritable bowel syndrome P.P.A. Humphrey, C. Bountra, Nick M. Clayton, Alimentary Pharmacology & Therapeutics	1999	94
Early histological features of small intestinal injury induced by indomethacin Anthony A. Attama, Amar P. Dhillon, G. Nygård, Alimentary Pharmacology & Therapeutics	1993	78
The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization Sharon Bingham, Paul Beswick, C. Bountra, Journal of Pharmacology and Experimental Therapeutics	2005	63
Gastric anti‐secretory, mucosal protective, anti‐pepsin and anti‐Helicobacter properties of ranitidine bismuth citrate R. Stables, Callum J. Campbell, Nick M. Clayton, Alimentary Pharmacology & Therapeutics Molecular PharmacologyMedicinal ChemistryBiochemistryGastrointestinal PharmacologyBismuth Citrate	1993	58
Changes in vanilloid receptor 1 (TRPV1) expression following lingual nerve injury James E. Biggs, J.R. Yates, Alison R. Loescher, European Journal of Pain Peripheral Nerve InjuryPain MedicineNeuropathic PainPathologyPeripheral Nerve	2006	54
Discovery of 1-[4-(3-Chlorophenylamino)-1-methyl-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridin-7-yl]-1-morpholin-4-ylmethanone (GSK554418A), a Brain Penetrant 5-Azaindole CB<sub>2</sub>Agonist for the Treatment of Chronic Pain Gerard M.P. Giblin, Andrew Billinton, Michael A. Briggs, Journal of Medicinal Chemistry	2009	53

Page 1